SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. & Its Board of ...
September 10 2014 - 5:33PM
Business Wire
Levi & Korsinsky announces that a class action lawsuit has
been commenced in the United States District Court for the District
of Nevada on behalf of investors who purchased Galectin
Therapeutics Inc. (“Galectin” or the “Company”) (NasdaqCM:GALT)
securities between January 6, 2014 and July 28, 2014.
For more information, click here:
http://zlk.9nl.com/galectin-therapeutics-galt.
The complaint alleges that during the Class Period, the Company
violated federal securities laws by issuing false and misleading
statements regarding its business and prospect. As a result of
these statements, Galectin stock traded at artificially inflated
prices.
On July 28, 2014, an article featured on TheStreet.com noted
that Galectin hired a stock promotions firm known as Emerging
Growth Corp. to tout its stock. The article further notes that
Emerging Growth “describes itself as an investor relations and
marketing company, but that it’s just a shiny façade on what is
really an ugly penny-stock promotions scheme.” The following day,
Galectin reported disappointing results regarding its phase 1
experimental drug trial for GR-MD-02.
If you suffered a loss in Galectin you have until September 29,
2014 to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Joseph
E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/galectin-therapeutics-galt.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut, and Washington D.C. The firm's 26
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Apr 2023 to Apr 2024